These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28892414)

  • 1. Efficacy of recombinant adenovirus expressing a fusion gene from GM-CSF and Epstein-Barr virus LMP2A in a mouse tumor model.
    Xue Q; Li X; Yang C; Ji B; Li Y; Yan Y; Yang X; Wang C; Chen T
    Hum Vaccin Immunother; 2017 Oct; 13(10):2260-2268. PubMed ID: 28892414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prime-boost immunization by both DNA vaccine and oncolytic adenovirus expressing GM-CSF and shRNA of TGF-β2 induces anti-tumor immune activation.
    Kim SY; Kang D; Choi HJ; Joo Y; Kim JH; Song JJ
    Oncotarget; 2017 Feb; 8(9):15858-15877. PubMed ID: 28178658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumour research of recombinant BCG using BZLF1 and hGM-CSF fusion genes.
    Xue QJ; Li YQ; Yang CQ; Chen T; Li XZ; Cheng B; Wang CM
    Vaccine; 2017 Mar; 35(12):1599-1607. PubMed ID: 28228322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EB virus-positive tumors are inhibited by rBCG expressing hGM-CSF and LMP2A.
    Yan Y; Xue QJ; Liu A; Wang H; Zhang H; Wang S; Zhao L; Li Y; Li X; Yang Y; Chen T; Li S
    Hum Vaccin Immunother; 2020 Mar; 16(3):654-663. PubMed ID: 31567046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of CSF2A fusion gene and its effect on Epstein-Barr virus-positive tumor cells.
    Sun Y; Long J; Yin Y; Li H; Jiang E; Zeng C; Zhu W
    J Med Virol; 2018 Nov; 90(11):1750-1756. PubMed ID: 29900557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tumor immunity against nasopharyngeal carcinoma by means of LMP2A-specific cytotoxic T lymphocytes induced by dendritic cells.
    Xu JJ; Yao K; Yu CJ; Chen X; Lu MP; Sun H; Li BZ; Ding CN; Zhou F
    Auris Nasus Larynx; 2006 Dec; 33(4):441-6. PubMed ID: 16934422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of T-cell immunity against Epstein-Barr virus-associated tumors by means of adenovirally transduced dendritic cells.
    Sun H; Yao K; Chen Y; Zhou F
    Chin Med J (Engl); 2004 Oct; 117(10):1558-63. PubMed ID: 15498383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Construction of recombinant adenovirus vector expressing extracellular domain of TbetaR-II-RANTES fusion gene and its anti-tumor effects].
    Wang XD; Liu H; Cao S; Li H; Ren XB; Hao XS
    Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):405-10. PubMed ID: 17974270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application of a tumor cell vaccine transfected with GM-CSF/IL-2 fusion gene for specific immunotherapy of hepatocellular carcinoma].
    Guo C; Liu QG; Yang W; Yao YM
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):188-92. PubMed ID: 18250039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic immunotherapy of established tumors with adenovirus-murine granulocyte-macrophage colony-stimulating factor.
    Lee CT; Wu S; Ciernik IF; Chen H; Nadaf-Rahrov S; Gabrilovich D; Carbone DP
    Hum Gene Ther; 1997 Jan; 8(2):187-93. PubMed ID: 9017422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific cellular immune responses in mice immunized with DNA, adeno-associated virus and adenoviral vaccines of Epstein-Barr virus-LMP2 alone or in combination.
    Wang Z; Yang S; Zhou L; Du H; Mo W; Zeng Y
    Sci China Life Sci; 2011 Mar; 54(3):263-6. PubMed ID: 21416326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant adenovirus expressing GP5 and M fusion proteins of porcine reproductive and respiratory syndrome virus induce both humoral and cell-mediated immune responses in mice.
    Jiang W; Jiang P; Li Y; Tang J; Wang X; Ma S
    Vet Immunol Immunopathol; 2006 Sep; 113(1-2):169-80. PubMed ID: 16777236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of a recombinant-BCG containing the LMP2A and BZLF1 genes and its significance in the Epstein-Barr virus positive gastric carcinoma.
    Xue QJ; Dai J; Li XZ; Zhu W; Si CP; Chen T
    J Med Virol; 2014 Oct; 86(10):1780-7. PubMed ID: 24699993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carrier cell-mediated delivery of a replication-competent adenovirus for cancer gene therapy.
    Hamada K; Desaki J; Nakagawa K; Zhang T; Shirakawa T; Gotoh A; Tagawa M
    Mol Ther; 2007 Jun; 15(6):1121-8. PubMed ID: 17387337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Construction and immunogenicity of recombinant adenovirus tandem expressing M and GP5 of porcine reproductive and respiratory syndrome virus].
    Jiang WM; Jiang P; Li YF; Tang JY; Wang XW; Du YJ
    Sheng Wu Gong Cheng Xue Bao; 2006 Jul; 22(4):555-60. PubMed ID: 16894887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-transmissible Sendai virus encoding granulocyte macrophage colony-stimulating factor is a novel and potent vector system for producing autologous tumor vaccines.
    Inoue H; Iga M; Nabeta H; Yokoo T; Suehiro Y; Okano S; Inoue M; Kinoh H; Katagiri T; Takayama K; Yonemitsu Y; Hasegawa M; Nakamura Y; Nakanishi Y; Tani K
    Cancer Sci; 2008 Nov; 99(11):2315-26. PubMed ID: 18957055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy.
    Stagg J; Wu JH; Bouganim N; Galipeau J
    Cancer Res; 2004 Dec; 64(24):8795-9. PubMed ID: 15604233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of IL-2 and GM-CSF immunocytokines to a tumor vaccine leads to increased anti-tumor activity.
    Fournier P; Aigner M; Schirrmacher V
    Int J Oncol; 2011 Jun; 38(6):1719-29. PubMed ID: 21424118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.